Company intelligence / Profile preview

Etex Group

Cambridge, MA, USA

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Etex was a Cambridge-based biotechnology company focused on the development of advanced calcium phosphate-based bone substitute materials. The company's core technology involved bioresorbable materials that mimic the mineral phase of natural bone, facilitating rapid healing and remodeling. Their product line, including Beta-bsm and Equivabone, addressed clinical needs in orthopedics, trauma, and dental surgery. Etex was acquired by Zimmer Holdings in 2014 to expand Zimmer's orthobiologics portfolio. Today, its technologies are integrated into Zimmer Biomet's surgical solutions.

Therapeutic areas: RheumatologyOther
Modalities: BioceramicsSynthetic bone minerals
Industry: Surgical Medical Devices

Partnerships

MedtronicZimmer Biomet

Beyond the preview

Go deeper on Etex Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Etex Group.

Explore the full profile